Biotechnology company Aveo Pharmaceuticals Inc. said Wednesday it plans on raising about $86.3 million in an initial public stock offering, according to Associated Press.
The Cambridge, Mass.-based company has not yet disclosed how many shares it plans on offering or set a pricing range. Aveo plans to list on Nasdaq under the "AVEO" ticker.
MicroCap Insider is a web-based financial portal.
Sign Up for our Free Stock Newsletter
MicroCap Insider publishes a free penny stock newsletter providing stock alerts on companies positioned to deliver high-yield gains to investors.
The joint book-running managers of the proposed offering will be J.P. Morgan Securities Inc. (NYSE: JPM) and Morgan Stanley & Co. Inc. (NYSE: MS).
The company's lead product candidate is Tivozanib, which is now in last-stage development as a renal cell cancer treatment.
Sign Up for FREE. Investors interested in receiving small cap stock alerts through the penny stock newsletter published by MicroCap Insider can sign up for free by visiting our website.
About Us
MicroCap Insider is a leading penny stock web site with extensive experience in the OTC market, providing top stock picks, investing tips and exclusive research on small cap stocks on the verge of producing large financial gains.
Please click here to read the full disclaimer.
